Scott D. Grimes - 16 Dec 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Issuer symbol
CDLX
Transactions as of
16 Dec 2021
Net transactions value
-$505,180
Form type
4
Filing time
20 Dec 2021, 16:41:18 UTC
Previous filing
13 Dec 2021
Next filing
04 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock Will/Inheritance $0 +55,832 $0.000000 55,832 31 Dec 2020 See Footnote F1
transaction CDLX Common Stock Sale $40,339 -640 -1.2% $63.03* 54,472 16 Dec 2021 See Footnote F2, F3, F4
transaction CDLX Common Stock Sale $40,883 -640 -1.2% $63.88* 53,832 16 Dec 2021 See Footnote F2, F4, F5
transaction CDLX Common Stock Sale $20,838 -320 -0.59% $65.12* 53,512 16 Dec 2021 See Footnote F2, F4, F6
transaction CDLX Common Stock Sale $26,400 -400 -0.75% $66.00* 53,112 16 Dec 2021 See Footnote F2, F4, F7
transaction CDLX Common Stock Sale $124,044 -2,002 -0.78% $61.96 254,026 20 Dec 2021 Direct F8, F9
transaction CDLX Common Stock Sale $156,700 -2,498 -0.98% $62.73* 251,528 20 Dec 2021 Direct F8, F10
transaction CDLX Common Stock Sale $83,044 -1,300 -0.52% $63.88* 250,228 20 Dec 2021 Direct F8, F11
transaction CDLX Common Stock Sale $12,932 -200 -0.08% $64.66* 250,028 20 Dec 2021 Direct F8, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F2 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.45 to $63.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5), (6), (7), (9), (10), (11) and (12) to this Form 4.
F4 The reportable securities are held by the GRAT.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.45 to $64.43, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.56 to $65.55, inclusive.
F7 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $65.62 to $66.60, inclusive.
F8 These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended June 15, 2021.
F9 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $61.34 to $62.30, inclusive.
F10 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $62.34 to $63.27, inclusive.
F11 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $63.60 to $64.50, inclusive.
F12 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $64.61 to $64.70, inclusive.